or Try an Advanced Search...

    ETF Components for IBDP - iShares iBonds Dec 2024 Corporate ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ABBV D 1.85 0.76
    CAF B 0.16 0.67

    Represented by ETF Holdings

    Keywords: Adalimumab Advanced Prostate Cancer Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder ETF Endometriosis Exchange Traded Fund Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Hypothyroidism
    Industries: Drug Manufacturers - Major

    Recent News for iShares iBonds Dec 2024 Corporate ETF & its Holdings

    Date Stock Title
    May 3 ABBV Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
    May 3 ABBV Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
    May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
    May 2 ABBV The top pharmaceutical companies by R&D expenditure
    May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
    May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
    Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
    Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
    Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
    Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
    Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
    Apr 29 ABBV AbbVie: The Inevitable Is Happening
    Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
    Apr 29 ABBV Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    Apr 28 ABBV Dividend Stock Portfolio For Income: Top 15 Stocks
    Apr 28 ABBV AbbVie First Quarter 2024 Earnings: Beats Expectations
    Apr 28 ABBV Better Dividend Stock: AbbVie or Johnson & Johnson?
    The investment seeks to track the investment results of the Barclays December 2024 Maturity Corporate Index which composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2024. The fund generally invests at least 80% of its assets in the securities of its underlying index, except during the last months of the fund's operations. The underlying index includes U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $250 million or more of outstanding face value at the time of inclusion. The fund is non-diversified.
    Exchange Traded Fund ETF Bond Corporate Bond Bond Market Indices Merrill Lynch Merrill Lynch Domestic Master Sukuk
    Back to the Main IBDP Page...